# KM03 Preference Label 1 - Transcript A vs B (workspace backup)

Stage: Step 15 Preference Labeling (Healthcare_247_Merrow - Task c8izef70, batch 20260608_173600).
Current status: DRAFT for platform entry after FA/GA AutoQC passed.

Studio-selected pair:
- Transcript A = 0.900 (bundle 02a01e69-253d-4762-a22c-07f066841145), 44 steps, 12m 27s, 5 pages.
- Transcript B = 0.880 (bundle c2b366c8-9afa-400f-9eed-1e3cc8e3e11c), 51 steps, 14m 39s, 6 pages.

Both deliverables read in full against golden-KM03-v2.2.docx and grader-guidelines-task3-v2.2.txt before labeling.

KEY FINDING: Both attempts caught the central CPAP/OSA fabrication plant and did not propagate it. Both produced complete, usable transition-of-care summaries. Both correctly withheld a numeric prednisone dose, kept pending coordination items as pending, and covered all required domains. The difference is narrow: A's CPAP handling explicitly cites the absence of objective device data and in-lab titration (matching the golden's exact reasoning), while B records adherence as "variable per home report" without stating the source-limitation basis. Both are clinically correct; the gap is reasoning precision on the central pattern, not clinical safety.

VERDICT: A1 (A slightly better). Button = plain "A" (no plus signs).

## Justification

Preferred output: A

A is slightly preferred over B. Both attempts caught the central CPAP/OSA fabrication and produced complete, source-faithful transition-of-care summaries covering held medications, pending coordination items, prednisone uncertainty, functional status, family supervision, and follow-up. Neither propagated the draft's unsupported claim that CPAP settings were recently reviewed and adherence adequate on the device. The gap comes down to how precisely each frames the CPAP reasoning and how closely that framing tracks the golden's own logic.

Justification: A explicitly states there is "no recent objective device download or in-lab titration" and that "CPAP adherence has been variable by home report," then frames the review as needed at outpatient follow-up. This matches the golden's reasoning that the only sleep study on file is the 2019 diagnostic polysomnography, there is no recent in-lab titration, and adherence is not device-verified. B records "OSA confirmed on 2019 polysomnography, adherence variable per home report" and says "no additional sleep follow-up is arranged for this transition; reinforce nightly CPAP use" but does not articulate the source-limitation reasoning (why adequacy cannot be claimed). Both are correct; A is more precise on the central scored pattern.

Prompt adherence: Both deliver the requested finalized discharge-planning summary covering all domains the prompt asks for. Both complete the draft into a chart-ready document the attending could file and the family could reference. This dimension is a tie.

Correctness: Both are accurate against the 26-file chart. Both catch the CPAP fabrication, both withhold a numeric prednisone dose and explain why, both keep the five held cardiorenal agents held with staged outpatient restart, both correctly leave pending coordination items (home-health acceptance, equipment delivery, transportation, supervision assignment, family teach-back) as pending rather than asserting them complete. Neither fabricates interval data, a final medication list, or a discharge order. No clinical error in either attempt.

Completeness: Both cover functional status and fall risk (Morse 65, rolling walker, supervised mobility), cognition and medication management (OT findings, pre-filled organizer, family verification), all ongoing conditions, home services and equipment, supervision and family teaching, follow-up appointments with named clinicians, and return precautions. B is slightly more elaborated in its checklist format (formal checkbox items with blanks for initials/dates). A includes an "Items to Confirm" section that covers the same open items in a narrative checklist. No material domain is missing from either.

Methodology: Both work systematically from the chart and verify claims against source documents before including them. A explicitly documents why the CPAP claim cannot stand (no device download, no titration, variable per home report only). B identifies the same conclusion but with less explicit derivation. Both correctly distinguish what the record supports from what remains in coordination. The approaches are equally sound; A's sourcing on the central pattern is marginally more transparent.

Quality and clarity: A is a tighter narrative at 5 pages with prose that reads like a hospitalist filing a chart document. B is 6 pages with a more structured/bulleted format and a formal checkbox checklist. Both are physician-facing and co-signable. A reads slightly closer to the golden's own register (narrative prose with headings rather than heavy bullet lists). This is a mild stylistic edge, not a clinical one.

Summary: A is preferred because its handling of the central CPAP/OSA pattern is more precisely reasoned (explicitly citing the absence of device data and titration, matching the golden), while B reaches the same correct conclusion with less explicit source-limitation articulation. Both are clinically correct on every domain and neither falls for the designed trap. The difference is reasoning transparency on the central scored failure, not clinical adequacy, which is why this is a slightly-better A1 rather than a wider gap.

## Guardrails (must survive any edit)
1. No sentence names a clinical error in B (there is none).
2. CPAP stated as handled correctly by BOTH (do not claim B propagated the plant).
3. Strongest word for the gap stays "marginally" / "slightly" - this is A1, not A2.
4. Per Abi 6/7: this is PL 1 of 3 required for KM03; two more on different trajectories needed.

## Submit mechanics
Select plain A -> paste justification (from "Preferred output: A" through "Summary" section) into Comments -> Submit Preference -> confirm entry shows in submission history -> run Preference Labels AutoQC.
